INVO Fertility, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
INVO Fertility, Inc. (IVF) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $100098.03 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-06-02.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2026-06-02
- INVO Fertility, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2025-03-31 was $770.50, a 2154.24% increase year-over-year.
- INVO Fertility, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2024-03-31 was $34.18, a 765.32% increase year-over-year.
- INVO Fertility, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2023-03-31 was $3.95.
- INVO Fertility, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2025 was $100098.03, a 26200.06% increase from fiscal 2024.
- INVO Fertility, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2024 was $380.60, a 596.69% increase from fiscal 2023.
- INVO Fertility, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2023 was $54.63, a 586.31% increase from fiscal 2022.
- INVO Fertility, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2022 was $7.96, a 12.53% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2025-12-31 | $100098.03 10-K · filed 2026-06-02 | |||
| 2025-09-30 | $2313.11 10-Q · filed 2025-11-17 | |||
| 2025-06-30 | $2313.11 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | $770.50 10-Q · filed 2025-05-20 | |||
| 2024-12-31 | $380.60 10-K · filed 2025-04-30 | |||
| 2024-09-30 | $31.58 10-Q · filed 2024-11-19 | |||
| 2024-06-30 | $31.58 10-Q/A · filed 2024-11-19 | |||
| 2024-03-31 | $34.18 10-Q · filed 2024-05-15 | |||
| 2023-12-31 | $54.63 10-K/A · filed 2024-11-19 | |||
| 2023-09-30 | $70.68 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | $72.38 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | $3.95 10-Q · filed 2023-05-15 | |||
| 2022-12-31 | $7.96 10-K · filed 2023-04-17 | |||
| 2022-09-30 | $3.89 10-Q · filed 2022-11-14 | |||
| 2021-12-31 | $9.10 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |